FdaApplication

ANDA 202910

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHETERO LABS LTD UNIT V
application_typeANDA
approval_date2012-09-27

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN150MGTABLET;ORAL
IRBESARTANIRBESARTAN75MGTABLET;ORAL
IRBESARTANIRBESARTAN300MGTABLET;ORAL

3 products